Jiaqiong Xu
Papers
3
Total Citations
5
H-Index
1
About
Jiaqiong Xu is a clinical researcher whose work focuses on the comparative effectiveness of surgical approaches in urologic oncology, particularly for bladder and kidney cancers. Her research leverages large national databases—including the National Surgical Quality Improvement Program (NSQIP) and the National Inpatient Sample (NIS)—to provide real-world evidence on outcomes of open, laparoscopic, and robotic surgeries. Her most cited paper, "Contemporary morbidity and mortality of open versus robotic cystectomy for bladder cancer" (2024), analyzes a targeted NSQIP dataset to compare perioperative complications between surgical techniques, offering critical insights for clinical decision-making. Xu also co-authored a study on trends in nephrectomy approaches for renal cancer, using the NIS database to track shifts toward minimally invasive surgery, and a 2025 comparison of robotic versus laparoscopic radical nephrectomy for renal cell carcinoma, which evaluates mortality and morbidity outcomes. Her work is notable for its use of large-scale, procedure-specific datasets to address gaps in surgical evidence. With a growing citation footprint, Xu’s research is shaping the conversation around optimal surgical strategies in urologic oncology, providing data-driven guidance for surgeons and patients alike.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3